Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma

BACKGROUND: The efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. However, the composition of other immune components in CCP and their potential rol...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Bonny, Tania S, Patel, Eshan U, Zhu, Xianming, Bloch, Evan M, Grabowski, M Kate, Abraham, Alison G, Littlefield, Kirsten, Shrestha, Ruchee, Benner, Sarah E, Laeyendecker, Oliver, Shoham, Shmuel, Sullivan, David, Quinn, Thomas C, Casadevall, Arturo, Pekosz, Andrew, Redd, Andrew D, Tobian, Aaron A R
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Major Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7717355/
https://ncbi.nlm.nih.gov/pubmed/33553467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa574
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars